Replimune Group

General Information
Business:

 

We are a clinical-stage biotechnology company committed to applying our leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients. We use our proprietary Immulytic platform to design and develop product candidates that are intended to maximally activate the immune system against cancer.

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 44
Founded: 2017
Contact Information
Address 18 Commerce Way, Woburn, MA 01801, US
Phone Number (781) 995-2443
Web Address https://www.replimune.com
View Prospectus: Replimune Group
Financial Information
Market Cap $462.6mil
Revenues $0 mil (last 12 months)
Net Income $-19.7 mil (last 12 months)
IPO Profile
Symbol REPL
Exchange NASDAQ
Shares (millions): 6.7
Price range $15.00 - $15.00
Est. $ Volume $100.5 mil
Manager / Joint Managers J.P. Morgan/ Leerink Partners/ BMO Capital Markets
CO-Managers -
Expected To Trade: 7/20/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change